 (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that 

 (TCS) has joined The Network, effective August 1, 2024. The practice is the largest community-based oncology provider in eastern Tennessee and the third largest oncology practice in the state. With the addition of TCS, The Network significantly extends its reach into eastern Tennessee while the practice enhances its ability to provide cancer patients in the region convenient access to high-quality, cutting-edge cancer care.

“We are pleased to welcome Tennessee Cancer Specialists to The Network, as it allows us to collaborate with a well-known, long-standing provider of high-quality community-based cancer care,” said Devon Womack, president, The US Oncology Network. “We share like-minded goals to advance cancer care while strengthening the practice’s ability to remain independent and viable in today’s challenging value-based landscape.”

As part of The Network, TCS can now utilize the deep expertise and substantial resources of The Network. The practice’s clinical staff can collaborate with their colleagues across The Network, tapping into the collective knowledge and experience of more than 2,600 independent providers across the U.S. The practice can also access The Network’s clinical and business consulting services, as well as innovative technologies that support high-quality patient care, efficient drug management, and revenue cycle optimization.

“We have had significant growth over the last few years, and we plan to continue this expansion by entering new markets, adding physicians, and building new service lines,” said 

, practice president, Tennessee Cancer Specialists. “The comprehensive resources and expert guidance from The Network will be invaluable as we move forward on this growth path while continuing to provide the high level of cancer care our patients and referring physicians have come to know and expect.”

, allowing TCS to benefit from a comprehensive suite of solutions and services. From access to 

 cutting-edge technologies enabling enhanced patient referral, patient intake, and provider workflow as well as simplified genomic test ordering and result capture, to increased access to innovative clinical trial opportunities, McKesson’s unapparelled oncology portfolio can help community-based practices like TCS thrive, so they can best care for their patients.

, the practice is especially eager to engage in clinical research through 

 (SCRI). Since its inception, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the FDA today. In collaboration with SCRI, TCS will be able to provide patients convenient access to some of the most innovative investigational therapies in the communities where patients live.

“The stability, experience, resources, and professionalism of The Network drew us to the organization,” Dobbs stated. “We are excited to collaborate with this highly respected group of independent providers to achieve our mutual goal of bringing advanced cancer care to more communities.”

TCS is the premier provider of advanced cancer care in eastern Tennessee with 15 physicians and 45 advanced practice providers (APPs) delivering world-class cancer care across 16 locations. The practice is committed to putting the patient first by delivering high-quality, compassionate, evidence-based care designed specifically to meet the unique needs of each patient. A full-service, comprehensive medical oncology and hematology practice, TCS offers onsite infusion centers, cutting-edge clinical trials, on call 24/7 support, knowledgeable billing and insurance staff, financial counseling and patient assistance, plus in-office pharmacy services for added convenience. The practice also provides non-oncology injections and infusions for patients who require specialty infusion services for other conditions, giving patients the convenience of dealing with one facility for all their infusion needs.

The physicians and APPs of TCS are among many who have recently joined The Network. Within the last 18 months, The Network has welcomed more than 400 new providers into the organization. This continued growth trajectory is significantly increasing the availability of advanced cancer care in local communities from strong, viable, and independent practices.


Tennessee Cancer Specialists, PLLC was founded in 2004 when East Tennessee Oncology and Hematology merged with Cancer Care of East Tennessee to become the largest private, independent cancer practice in eastern Tennessee and the third largest oncology group in the state of Tennessee. The practice has offices in eight counties to conveniently serve patients in Knoxville and surrounding communities. At Tennessee Cancer Specialists, their mission is to provide the highest quality compassionate care, to meet the unique needs of patients with cancer, and to assist them and their families to focus on recovery.

 (The Network) helps more than 2,600 independent providers deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure, and support of 

. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. The Network is committed to the success of independent practices, everywhere.

About McKesson Oncology and Specialty Solutions


It’s an unprecedented time for patients living with cancer as life sciences companies race to create new, cutting-edge therapies. With cancer care becoming more targeted, providers, life sciences companies, and payers face a multitude of challenges and complexity in the development of new treatments and making them accessible to patients in need. At 

, our unmatched portfolio of oncology businesses and partners provide research, insights, technologies, and services that are helping to address these hurdles and improve cancer and specialty care.

McKesson is fueling discovery by helping patients participate in cutting-edge clinical trials closer to home through the joint venture between US Oncology Research and 

 are advancing specialty care and high-quality cancer care in the communities where patients live by supporting the practices of thousands of independent, community-based providers.

®, a McKesson business dedicated to oncology, generates real-world data (RWD) and real-world evidence (RWE), and provides clinical education and provider technology to inform and improve cancer care.

As one of the largest distributors of oncology and specialty medicines, we are ensuring medicines make their way to those who are counting on them.

, our work continues to help patients access, afford, and adhere to their medicines.

Articles

Tennessee Cancer Specialists, the third largest oncology practice in the state, strengthens its ability to deliver cutting-edge advanced care by joining The Network.

The US Oncology Network Expands its Tennessee Service Area as Tennessee Cancer Specialists Joins The Network

), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that Nashville Oncology Associates (NOA) has joined The Network, effective October 1st.

“We are eager to have Nashville Oncology Associates join us on our mission to increase access to convenient, high-quality cancer care in the Nashville region,” said Jason Hammonds, president, The US Oncology Network. “As we welcome these highly skilled cancer specialists into The Network, we extend our reach of comprehensive community-based services into Tennessee for the first time. Our goal is that our support and resources will help enhance the high-quality care NOA provides to patients in the community.”

Nashville Oncology Associates provides comprehensive cancer treatment services and advanced technological options to patients from providers with extensive clinical expertise. The practice treats blood cancers and disorders, as well as bone, breast, lung, reproductive, skin, gastrointestinal, colorectal, and urinary tract cancers, nurturing an atmosphere of trust and compassion. The practice offers care from an advanced practice provider and two physicians, Karl M. Rogers, M.D., practice president and medical oncologist, and Carl R. Willis, M.D., medical oncologist.

“Joining The Network will provide access to a wealth of operational and clinical resources that will help us continue to deliver superior care while empowering us to remain independent in today’s challenging environment,” said Dr. Rogers.

The US Oncology Network continues to grow and be the source of best practices in the application of value-based, high-quality care. More than 2,400 providers in The Network treat over 1.4 million patients annually at approximately 600 sites of care in 30 states. This growing footprint greatly enhances the member practices’ ability to remain independent while increasing access to advanced cancer care in local and rural communities.

The Network continues its strong growth trajectory and its mission to enhance community-based cancer care.

The US Oncology Network Extends Its Reach into Tennessee with The Addition of Nashville Oncology Associates

 business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Christine Davis as its new president. In this role, Davis will focus on growing the business and fostering innovation, all to improve the lives of patients and win the fight against cancer. With more than 25 years of experience in the life sciences industry, Davis possesses an impressive background in oncology research and real-world data.

“Christine has a strong track record of driving significant business growth and transformation,” said Kirk Kaminsky, president of Pharmaceutical Solutions and Services at McKesson. “We’re confident she will lead the way in harnessing Ontada’s real-world data and evidence, along with McKesson’s unmatched portfolio of oncology services, to improve health outcomes for patients living with cancer.”

In her newly appointed position, Davis will advance Ontada’s real-world data and evidence services that are helping to accelerate drug development and commercialization, educate providers on new treatments, and advance precise, evidence-driven patient care. Additionally, she aims to enhance 

Ontada’s healthcare technology solutions

Previously, Davis served as the Oracle Life Sciences’ Global Head of Commercial Research & Consulting for Cerner Enviza. She worked her way into life sciences leadership while at Kantar Health, a data analytics and research company focused on oncology and rare diseases later acquired by Cerner. At Kantar, Davis led the research business and directed U.S. primary research and analytics into opportunities for growth, differentiation, and innovation on behalf of the world’s top pharmaceutical companies. She later served as global head of oncology and specialty therapeutics where she led the company’s oncology data and products business. Davis holds a master’s from Northeastern University and a BS in Nutrition and Biochemistry from Syracuse University.

“Playing an integral part in improving the lives of cancer patients is something to be proud of, and it drives me to go to work with such purpose. I am glad to be joining Ontada’s amazing team, whose members have the same passion to drive transformation and innovation in an ever-evolving field,” said Davis. “With the support of McKesson and the strength of Ontada, I see so much opportunity to bring real and powerful impact to patient lives.”

Ontada, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Christine Davis as its new president. 

Ontada Names Christine Davis Its New President

The Woodlands, Texas, July 10, 2023 — The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced that Cancer Center of Kansas (CCK) has joined The Network, effective July 1, 2023, by entering into a new managed services partnership. This addition expands The Network’s service area into Kansas and continues its strong growth trajectory with nearly 240 providers joining The Network since the beginning of the calendar year.

“Cancer Center of Kansas has been a long-time McKesson customer, and we are excited to enhance our relationship with these highly-skilled cancer specialists by welcoming them into The Network,” said Jason Hammonds, president, The US Oncology Network. “The addition of the practice extends our reach of comprehensive services into Kansas while offering the practice innovative solutions, technologies, and expertise that will help them remain viable in today’s complex healthcare landscape.”

A leading cancer provider across Kansas for more than 40 years, CCK is and will remain the largest physician-owned, independent practice in the state with 13 physicians and six advanced practice providers delivering care from 20 sites of service. CCK brings high-quality cancer care to rural areas in Kansas through a committed and dedicated team of over 300 employees, including more than 90 nurses, so patients can receive the very latest advancements in cancer treatments and research in the communities where they live and work.

By becoming a member of The Network, CCK gains access to a wealth of resources that will strengthen its ability to deliver high-quality community cancer care while remaining independent. As part of The Network, the practice greatly increases opportunities for their patients to participate in clinical trials, as The Network is a worldwide leader in cancer research.

“The US Oncology Network is a perfect fit for us, as we have a shared commitment to clinical research,” said Shaker R. Dakhil, MD, FACP, practice president, Cancer Center of Kansas. “We will be collaborating with like-minded individuals in The Network who are dedicated to advancing cancer care with the goal of discovering new therapies for those facing this difficult disease.”

Cancer Center of Kansas can utilize the substantial resources of The Network, an integrated and supportive organization dedicated to helping providers maintain their independence and prosper in today’s challenging environment. Additionally, CCK’s clinical staff can collaborate with their colleagues across The Network, tapping into the collective knowledge and experience of more than 2,300 independent providers across the U.S.

“We are committed to continuing to bring the very latest cancer care and research to the state of Kansas,” said Dr. Dakhil. “Joining The Network provides us innovative clinical and business consulting services and advanced technologies that will help us succeed in today’s complex value-based environment.”

The US Oncology Network announced that the Cancer Center of Kansas has joined The Network by entering into a new managed services partnership.

Cancer Center of Kansas Joins The US Oncology Network

Terrill Jordan, president and chief executive officer, RCCA

The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced that Regional Cancer Care Associates (RCCA) entered into a strategic relationship with The Network effective April 1, 2023. RCCA has more than 20 sites of service located throughout New Jersey, Maryland, Connecticut, and the Washington, D.C. area. The practice’s 94 physicians and 59 advanced practice providers (APPs) offer medical, radiation, and gynecologic oncology and hematology care in addition to genetic testing, specialty pharmacy services, and clinical trials.

“Regional Cancer Care Associates is a perfect fit for The US Oncology Network as both organizations seek to put the patient first,” said Jason Hammonds, president, The US Oncology Network. “With like-minded goals to enhance care and the patient experience, and grow the practice and its services, RCCA and The Network are enthusiastic about working together.”

RCCA will now have access to the substantial expertise and ample resources of The Network. The practice’s clinical staff will collaborate with their colleagues across The Network, adding to the collective knowledge and experience of more than 2,300 independent providers across the U.S. Additionally, RCCA will leverage The Network’s clinical and business consulting services and innovative technologies that support high-quality patient care, efficient drug management, and revenue cycle optimization.

“We take great pride in being an independent practice that provides cutting-edge treatments in a community setting,”said Terrill Jordan, president and chief executive officer, RCCA. “It’s important to our dedicated providers and staff to collaborate with an organization that can deliver the resources that help us grow, thrive, and succeed, all while empowering us to retain our independence. For two years, we worked with Cross Keys Capital, The Bloom Organization, and Arnold & Porter to conduct a comprehensive search to find a strategic partner that shares our vision and values. We confidently entered into partnership with The US Oncology Network and look forward to executing on our shared commitment to grow our services and footprint in order to bring quality care to more communities.”

The physicians and APPs of RCCA are among many who have recently joined The US Oncology Network. Within the last year, The Network, supported by McKesson Corporation, has welcomed more than 450 new providers into the organization. This continued growth trajectory is significantly increasing the availability of advanced cancer care in local communities from strong, viable, and independent practices.

The US Oncology Network announced that Regional Cancer Care Associates entered into a strategic relationship with The Network effective April 1, 2023

The US Oncology Network

Articles

The US Oncology Network Expands its Tennessee Service Area as Tennessee Cancer Specialists Joins The Network

The US Oncology Network Extends Its Reach into Tennessee with The Addition of Nashville Oncology Associates

Ontada Names Christine Davis Its New President

Cancer Center of Kansas Joins The US Oncology Network

Regional Cancer Care Associates Joins The US Oncology Network